Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Organisation

Trials

  • NCT04636437

    Phase 4, Completed, 147 people, 19 Nov 2020

  • NCT03070223

    Phase 3, Completed, 602 people, 3 Mar 2017

  • NCT02582684

    Phase 2, Completed, 122 people, 21 Oct 2015

  • NCT02563327

    Collaborator, Phase 3, Completed, 2,516 people, 30 Sept 2015

  • NCT02513771

    Phase 2, Completed, 90 people, 3 Aug 2015

  • NCT02440789

    Phase 1/2, Completed, 32 people, 12 May 2015

  • NCT02155985

    Phase 2, Completed, 121 people, 4 Jun 2014

  • NCT01936831

    Phase 2, Completed, 282 people, 6 Sept 2013

  • NCT01903031

    Phase 2, Completed, 84 people, 19 Jul 2013

  • NCT01777997

    Phase 4, Completed, 38 people, 29 Jan 2013

  • NCT01641367

    Phase 4, Completed, 545 people, 16 Jul 2012

  • NCT01632891

    Phase 1/2, Completed, 52 people, 3 Jul 2012

  • NCT01601626

    Phase 2, Terminated, 71 people, 18 May 2012

  • NCT01515813

    Phase 2, Withdrawn, 0 people, 24 Jan 2012

  • NCT01505114

    Collaborator, Phase 2, Completed, 594 people, 6 Jan 2012

  • NCT01435018

    Phase 3, Completed, 334 people, 15 Sept 2011

  • NCT01426438

    Phase 2, Completed, 99 people, 31 Aug 2011

  • NCT01403051

    Phase 2, Completed, 167 people, 27 Jul 2011

  • NCT01400412

    Phase 2, Completed, 262 people, 22 Jul 2011

  • NCT01352715

    Phase 3, Completed, 515 people, 12 May 2011